James J. Mahoney

2.9k total citations
88 papers, 2.0k citations indexed

About

James J. Mahoney is a scholar working on Cellular and Molecular Neuroscience, Epidemiology and Clinical Psychology. According to data from OpenAlex, James J. Mahoney has authored 88 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cellular and Molecular Neuroscience, 22 papers in Epidemiology and 19 papers in Clinical Psychology. Recurrent topics in James J. Mahoney's work include Neurotransmitter Receptor Influence on Behavior (28 papers), Substance Abuse Treatment and Outcomes (15 papers) and Neurological disorders and treatments (8 papers). James J. Mahoney is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (28 papers), Substance Abuse Treatment and Outcomes (15 papers) and Neurological disorders and treatments (8 papers). James J. Mahoney collaborates with scholars based in United States, United Kingdom and Switzerland. James J. Mahoney's co-authors include Richard De La Garza, Thomas F. Newton, Ari D. Kalechstein, Colin N. Haile, Daisy G.Y. Thompson-Lake, Christopher D. Verrico, Patrick Marshalek, Ali R. Rezai, Lee C. Chang and James H. Berry and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Biological Psychiatry.

In The Last Decade

James J. Mahoney

88 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James J. Mahoney United States 27 901 437 335 331 314 88 2.0k
Ari D. Kalechstein United States 26 1.0k 1.1× 337 0.8× 418 1.2× 484 1.5× 529 1.7× 51 2.0k
Mark J. Sedler United States 18 1.7k 1.9× 362 0.8× 452 1.3× 657 2.0× 654 2.1× 62 3.1k
John Krystal United States 20 853 0.9× 430 1.0× 565 1.7× 338 1.0× 334 1.1× 34 2.0k
Elinore McCance United States 11 1.1k 1.2× 278 0.6× 176 0.5× 322 1.0× 583 1.9× 13 1.9k
Kelly E. Courtney United States 22 810 0.9× 310 0.7× 296 0.9× 613 1.9× 195 0.6× 64 2.1k
Peter S. Talbot United Kingdom 27 991 1.1× 320 0.7× 466 1.4× 427 1.3× 495 1.6× 53 2.5k
Ruth Salo United States 23 924 1.0× 167 0.4× 258 0.8× 876 2.6× 578 1.8× 34 1.9k
Gail Farfel United States 23 768 0.9× 590 1.4× 1.1k 3.3× 214 0.6× 960 3.1× 43 2.7k
Stefania Bonaccorso United Kingdom 25 722 0.8× 675 1.5× 285 0.9× 502 1.5× 1.1k 3.4× 35 3.2k
Andy C. Dean United States 22 611 0.7× 153 0.4× 218 0.7× 526 1.6× 363 1.2× 47 1.6k

Countries citing papers authored by James J. Mahoney

Since Specialization
Citations

This map shows the geographic impact of James J. Mahoney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James J. Mahoney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James J. Mahoney more than expected).

Fields of papers citing papers by James J. Mahoney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James J. Mahoney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James J. Mahoney. The network helps show where James J. Mahoney may publish in the future.

Co-authorship network of co-authors of James J. Mahoney

This figure shows the co-authorship network connecting the top 25 collaborators of James J. Mahoney. A scholar is included among the top collaborators of James J. Mahoney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James J. Mahoney. James J. Mahoney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rezai, Ali R., Tasneem Arsiwala, Michael K. E. Schäfer, et al.. (2025). Brain injury during focused ultrasound neuromodulation for substance use disorder. Brain stimulation. 18(6). 2050–2053. 2 indexed citations
2.
Rezai, Ali R., Daisy G.Y. Thompson-Lake, Pierre-François D’Haese, et al.. (2025). Focused Ultrasound Neuromodulation: Exploring a Novel Treatment for Severe Opioid Use Disorder. Biological Psychiatry. 98(1). 56–64. 7 indexed citations
3.
Ranjan, Manish, James J. Mahoney, & Ali R. Rezai. (2024). Neurosurgical neuromodulation therapy for psychiatric disorders. Neurotherapeutics. 21(3). e00366–e00366. 3 indexed citations
4.
Perle, Jonathan G., et al.. (2024). Changes in the Clinical Practice of Mental Health Service Providers Throughout the COVID-19 Pandemic: Longitudinal Questionnaire Study. JMIR Formative Research. 8. e50303–e50303. 2 indexed citations
5.
Mahoney, James J., et al.. (2023). Noninvasive Neuromodulation in Parkinson’s Disease: Insights from Animal Models. Journal of Clinical Medicine. 12(17). 5448–5448. 4 indexed citations
6.
Rezai, Ali R., James J. Mahoney, Manish Ranjan, et al.. (2023). Safety and feasibility clinical trial of nucleus accumbens deep brain stimulation for treatment-refractory opioid use disorder. Journal of neurosurgery. 140(1). 231–239. 18 indexed citations
7.
Mahoney, James J., Victor Finomore, Jad Ramadan, et al.. (2023). Identifying biomarkers of drug use recurrence using wearable device technologies and phone applications. Drug and Alcohol Dependence. 249. 110817–110817. 2 indexed citations
8.
Mahoney, James J., Marc W. Haut, Sally Hodder, et al.. (2021). Deep brain stimulation of the nucleus accumbens/ventral capsule for severe and intractable opioid and benzodiazepine use disorder.. Experimental and Clinical Psychopharmacology. 29(2). 210–215. 21 indexed citations
9.
Winstanley, Erin L., James J. Mahoney, Felipe Castillo, & Sandra D. Comer. (2021). Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review. Drug and Alcohol Dependence. 226. 108838–108838. 26 indexed citations
10.
Mahoney, James J., Erin L. Winstanley, Laura R. Lander, et al.. (2020). High prevalence of co-occurring substance use in individuals with opioid use disorder. Addictive Behaviors. 114. 106752–106752. 29 indexed citations
11.
Mahoney, James J., Patrick Marshalek, Ali R. Rezai, et al.. (2019). A case report illustrating the effects of repetitive transcranial magnetic stimulation on cue-induced craving in an individual with opioid and cocaine use disorder.. Experimental and Clinical Psychopharmacology. 28(1). 1–5. 15 indexed citations
12.
Mahoney, James J., Cady Block, John Linck, et al.. (2015). Relative Utility of Performance and Symptom Validity Tests. Archives of Clinical Neuropsychology. 31(1). 18–22. 26 indexed citations
13.
Verrico, Christopher D., Colin N. Haile, James J. Mahoney, et al.. (2014). Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study. Drug and Alcohol Dependence. 141. 72–78. 34 indexed citations
14.
Haile, Colin N., Richard De La Garza, James J. Mahoney, & Thomas F. Newton. (2013). Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase. Drug and Alcohol Dependence. 133(2). 759–762. 6 indexed citations
15.
Kalechstein, Ari D., et al.. (2012). Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users. Neuropharmacology. 64. 472–478. 41 indexed citations
16.
Mahoney, James J., et al.. (2012). The relationship between lifetime stress and addiction severity in cocaine-dependent participants. European Neuropsychopharmacology. 23(5). 351–357. 11 indexed citations
17.
Mahoney, James J., et al.. (2010). Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants. Gender Medicine. 7(5). 414–421. 36 indexed citations
18.
Newton, Thomas F., Malcolm S. Reid, Richard De La Garza, et al.. (2008). Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers. The International Journal of Neuropsychopharmacology. 11(8). 1037–1037. 47 indexed citations
19.
Mahoney, James J., Ari D. Kalechstein, Richard De La Garza, & Thomas F. Newton. (2007). A qualitative and quantitative review of cocaine-induced craving: The phenomenon of priming. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(3). 593–599. 25 indexed citations
20.
Wanner, Ina B., James J. Mahoney, Kristján R. Jessen, et al.. (2006). Invariant mantling of growth cones by Schwann cell precursors characterize growing peripheral nerve fronts. Glia. 54(5). 424–438. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026